Veracyte (VCYT) Tops Q2 EPS by 33c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
Tweet
Share
E-mailGet Alerts VCYT Hot Sheet
Join SI Premium – FREE
Veracyte (NASDAQ: VCYT) reported Q2 EPS of $0.44, $0.33 better than the analyst estimate of $0.11. Revenue for the quarter came in at $130.16 million versus the consensus estimate of $121.1 million.
GUIDANCE:
Veracyte sees FY2025 revenue of $496-504 million, versus the consensus of $491.9 million.
For earnings history and earnings-related data on Veracyte (VCYT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Simmons First National Corp (SFNC) Reports In-Line Q3 EPS
- Independent Bank (INDB) Tops Q3 EPS by 5c
- Loop Industries cuts India facility size to 45 KTA, posts $2.99M loss
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
